Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harmony Biosciences Holdings Inc (NQ: HRMY ) 33.08 +0.95 (+2.96%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Harmony Biosciences Holdings Inc Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028 August 06, 2024 From Harmony Biosciences Via GlobeNewswire Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy April 30, 2024 From Harmony Biosciences Via GlobeNewswire Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates February 22, 2024 From Harmony Biosciences Via GlobeNewswire Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results October 31, 2023 From Harmony Biosciences Via GlobeNewswire ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE August 17, 2023 From Kahn Swick & Foti, LLC Via Business Wire NASDAQ: HRMY Investor Alert: Investigation over Potential Wrongdoing at Harmony Biosciences Holdings, Inc. August 17, 2023 San Diego, CA -- (SBWIRE) -- 08/17/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Harmony Biosciences Holdings, Inc. Via SBWire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID) August 14, 2023 From Brodsky & Smith LLC Via GlobeNewswire Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates August 01, 2023 From Harmony Biosciences Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Techtronic, Boxed, Coinbase, and Harmony and Encourages Investors to Contact the Firm June 19, 2023 From Bragar Eagel & Squire Via GlobeNewswire Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates May 02, 2023 From Harmony Biosciences Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm April 23, 2023 From Bragar Eagel & Squire Via GlobeNewswire NASDAQ:HRMY Shareholder Alert: Investigation over Possible Securities Laws Violations by Harmony Biosciences Holdings, Inc. April 14, 2023 San Diego, CA -- (SBWIRE) -- 04/14/2023 -- An investigation was announced for investors of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) shares over potential securities laws violations by Harmony... Via SBWire Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm April 12, 2023 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Nutanix and Harmony and Encourages Investors to Contact the Firm April 02, 2023 From Bragar Eagel & Squire Via GlobeNewswire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors March 30, 2023 From Glancy Prongay & Murray LLP Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors March 30, 2023 From Law Offices of Howard G. Smith Via Business Wire HARMONY ALERT: Bragar Eagel & Squire, P.C. is Investigating Harmony Biosciences Holdings, Inc. on Behalf of Harmony Stockholders and Encourages Investors to Contact the Firm March 29, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Harmony Biosciences Holdings, Inc. and Encourages Investors with Losses to Contact the Firm March 29, 2023 From The Schall Law Firm Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors March 28, 2023 From The Law Offices of Frank R. Cruz Via Business Wire Lost Money in Harmony Biosciences Holdings Inc.? March 28, 2023 From Gibbs Law Group Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Harmony Biosciences Holdings, Inc. and Encourages Investors with Losses to Contact the Firm March 28, 2023 From The Schall Law Firm Via Business Wire EQUITY ALERT: Rosen Law Firm Encourages Harmony Biosciences Holdings, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – HRMY March 28, 2023 From The Rosen Law Firm, P.A. Via Business Wire Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates February 21, 2023 From Harmony Biosciences Via GlobeNewswire 2 Biotechs Making Waves With A Single Product in their Pipeline January 11, 2023 Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise. Via MarketBeat Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates November 01, 2022 From Harmony Biosciences Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
